Bcl-2 antagonists and cancer: from the clinic, back to the bench

被引:7
|
作者
M Degli Esposti
机构
[1] Faculty of Life Sciences,
[2] University of Manchester,undefined
关键词
D O I
10.1038/cddis.2010.15
中图分类号
学科分类号
摘要
引用
收藏
页码:e37 / e37
相关论文
共 50 条
  • [31] Cancer vaccine characterization: From bench to clinic
    de la Luz-Hernández, K.
    Rabasa, Y.
    Montesinos, R.
    Fuentes, D.
    Santo-Tomas, J. F.
    Morales, O.
    Aguilar, Y.
    Pacheco, B.
    Castillo, A.
    VACCINE, 2014, 32 (24) : 2851 - 2858
  • [32] Bcl-2 family proteins and cancer
    Yip, K. W.
    Reed, J. C.
    ONCOGENE, 2008, 27 (50) : 6398 - 6406
  • [33] IMMUNOTOXINS IN THE THERAPY OF CANCER - FROM BENCH TO CLINIC
    GHETIE, V
    VITETTA, E
    PHARMACOLOGY & THERAPEUTICS, 1994, 63 (03) : 209 - 234
  • [34] Targeting Bcl-2 for cancer therapy
    Zhang, Linlin
    Lu, Zaiming
    Zhao, Xiangxuan
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2021, 1876 (01):
  • [35] IGF system in cancer: from bench to clinic
    Chaves, Jorge
    Saif, Muhammad Wasif
    ANTI-CANCER DRUGS, 2011, 22 (03) : 206 - 212
  • [36] Bcl-2 family proteins and cancer
    K W Yip
    J C Reed
    Oncogene, 2008, 27 : 6398 - 6406
  • [37] Expression of bcl-2 and bcl-X in bladder cancer
    Kirsh, EJ
    Baunoch, DA
    Stadler, WM
    JOURNAL OF UROLOGY, 1998, 159 (04): : 1348 - 1353
  • [38] Oncological Risk After Autologous Lipoaspirate Grafting in Breast Cancer Patients: From the Bench to the Clinic and Back
    Wang, Yuan Yuan
    Ren, Guo Sheng
    Petit, Jean-Yves
    Muller, Catherine
    JOURNAL OF CRANIOFACIAL SURGERY, 2013, 24 (03) : 700 - 702
  • [39] RNA-based pharmacotherapy for tumors: From bench to clinic and back
    Liang, Xiangping
    Li, Dongpei
    Leng, Shuilong
    Zhu, Xiao
    BIOMEDICINE & PHARMACOTHERAPY, 2020, 125
  • [40] DIURETIC DRUGS AND THE TREATMENT OF EDEMA - FROM CLINIC TO BENCH AND BACK AGAIN
    ELLISON, DH
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1994, 23 (05) : 623 - 643